Skip to content

Explore the Agenda

Learn About Business at Wonderland

Our programming offers the most extensive coverage of the psychedelic medicine industry.

9:30 am

Explore Stage

National Psychedelic Policy: First Steps and Aspirations

Featuring Charles Eisenstein.

Psychedelics have until recently dwelt in the margins of society. How can we bring them into institutions that have long been hostile to them? How do we do that in a way that respects their lineages, and that fulfils their transformative potential on both the individual and on society? Charles will explore these questions from the near-term perspective of a presidential advisor as well as the long-term perspective of a social philosopher.

9:30 am

Expand Stage

Notes from the Underground: The Traditional Psychedelic Marketplace and the Future of the Legal Industry

Featuring Reggie Harris, Robert Johnson, Mary Carreon, Dennis Walker.

Media attention is fueling consumer demand for psychedelics faster than they can be legalized, and millions of people are already pursuing or consuming psychedelics in pursuit of better mental health. Anyone preparing business plans for psychedelic legalization will compete with a thriving underground psychedelic economy, one that actually benefits small-scale entrepreneurship and rewards community over competition. Attendees will gain a much clearer understanding of what Big Biotech’s market assessments are missing, and how the psychedelic market is evolving outside of legal channels.

10:00 am

Explore Stage

Patented Psychedelics: The Growing Pharma Field

Featuring Dr. David Wood, Jason Najum, Thomas Digby, Dr. Sam Clark, MD PhD.

A panel focused on the role of patents in protecting innovation, stimulating research, and shaping the competitive landscape.

10:00 am

The Sanctuary

A Tale of Two (High) Societies: UK Psychedelia and the American Land of the Free

Featuring Mattha Busby.

Why is the psychedelic revolution at a more advanced stage in the US than in the UK? The genesis of psychedelic science is in the US but it’s notable how the anachronistic UK lags behind. We will unpack the anomalies and realities of class, politics, botany, money, national character, empire and hegemony, evangelism, church, Druidry, and British psychedelia.

10:30 am

Explore Stage

Regulatory Initiatives

Featuring Ryan Munevar, Joshua Narrow, Melissa Lavasani, Gregory Ferenstein, Juliana Mercer, Charles Eisenstein.

Updates on the latest in psychedelic drug reform, legislative progress, and legalization in the USA.

10:30 am

Expand Stage

Tele-therapy and Digital Solutions for Mental Health

Featuring David Mou, Florencia Bollini, Holly Nelson, Nik Vassev, Emily Zaccardi, Patrick Hilsbos.

Exploring the rise of teletherapy and other digital solutions in mental health care, and their potential benefits and drawbacks.

11:00 am

Explore Stage

The Father of Biohacking Reveals a Secret to Radical Brain Longevity: Psychedelic-Level Neurofeedback

Featuring Dave Asprey.

As the pioneer who launched the global biohacking movement in 2011, Dave Asprey needs no introduction. Dave has devoted his life to elevating human performance and extending healthy lifespans using cutting-edge science. He has authored several NYT best-selling books on longevity and brain enhancement and is launching a $100 million longevity venture fund. In this highly anticipated talk, Dave will unveil new research from his company 40 Years of Zen, where he has developed proprietary neurotech to teach advanced meditation skills to top professionals. Through brainwave entrainment and neurofeedback, 40 Years of Zen helps users access profound altered states similar to psychedelics – without drugs. Dave will discuss the neurological mechanisms that make brains younger and longer lives.

11:00 am

Explore Stage

The Risks of Compounding Pharmacies: Widely Overlooked Problems & Proposed Solutions

Featuring Ariél Saint White, Christopher Teas, Layne Kilpatrick.

Compounding pharmacies play an important role in creating customized medications for patients with unique needs. However, these pharmacies also pose significant risks due to lack of FDA oversight on safety, effectiveness, and quality. This session will examine the overlooked problems associated with compounding pharmacies and proposed solutions.

11:30 am

Engage Stage

Avoiding the Fall Out of 280E

Featuring Justin Botillier.

This informative session, presented by Justin Botillier, CEO of Calyx CPA LLC, draws on sixteen years of experience working with small businesses and specific expertise in the cannabis and psychedelic industries. With the classification of psychedelics as Schedule I drugs, businesses in this sector are subject to 280E – a provision that often results in significant expenses. Justin was one of the first accountants to advocate for the cannabis industry and has since shifted his focus to the psychedelic community. His firm specializes in business advisory, entity formation, tax preparation, and tax planning for plant medicine companies. In this session, he will guide attendees through strategies to mitigate the impact of 280E, focusing on aggressive yet defensible tax positions that can help businesses navigate these unique tax challenges effectively and legally. This is an essential session for any business operating within the psilocybin industry.

11:30 am

Engage Stage

How to Customize AI for Your Work in a Way That’s Meaningful for Your Clients

Featuring Emily Zaccardi.

AI is everywhere we look, but what is its place in the mental health space? Can it actually create an impact for the goal of helping people navigate their complex emotions? Join our workshop that explores the meaning of empathic AI, and what it takes to deliver real value to people in need. Walk out with your CUSTOM demo of an AI that is designed to support your clients between their sessions! This is a hands-on experience related to your specialized, expert approach to supporting the well-being of others. Advance your own thinking about the ways AI does and doesn’t belong in the future of mental health within this workshop presented by Kai.ai.

12:00 pm

Explore Stage

Oregon and Colorado

Featuring Lisa Ginzburg, Courtney Barnes, Esq., Shawn Hauser.

Oregon and Colorado have paved the way for psychedelic therapy legalization. In 2020, Oregon passed Measure 109, allowing licensed facilitators to provide psilocybin services. In 2022, Colorado passed Proposition 122, legalizing supervised access to psychedelics like psilocybin and DMT. The panel will discuss these historic votes, how the states are implementing the laws, what services will look like, and who will have access. We’ll also explore emerging psychedelics research for treating conditions like depression, PTSD, and addiction. Our experts will share perspectives on the advances in Oregon and Colorado and the future of the sector.

12:00 pm

Engage Stage

Porta Sophia as a Resource: How a Non-Profit Psychedelic Prior Art Library Protects the Public Domain and Supports Good Patents

Featuring Sisi Li, Ph.D..

Intellectual property can enhance psychedelic businesses and return-on-investments. However, existing psychedelic ‘prior art’ can impact patent issuance and may be hard to access. Recent patents have overlooked prior art, risking costly post-grant disputes. Non-profit Porta Sophia offers a psychedelic prior art library and intervenes in patent examinations to protect the public domain and promote innovation by exploring best practices in psychedelic patenting.

12:00 pm

Expand Stage

Pharma and Biotech Business Development: What Are Companies Exploring in Psychedelics?

Featuring Stephen Hebert, Cody Powers.

As the pipeline of novel psychedelics has grown, so has pharma and biotech interest in partnering/investing with others who are developing new psychedelics. Although established pharma and biotech companies see significant potential to both improve the lives of patients and reach corporate growth ambitions, there are sometimes challenges to the psychedelic space – for example, intellectual property limitations or FDA scheduling – that can impact the willingness of companies to engage with would-be partners. This combination of opportunities and challenges has become the lens that companies large and small look through when analyzing whether and how they look to acquire, fund, or partner for growth into psychedelics. In this fireside chat, we will explore how pharma and biotech companies are assessing business development opportunities in psychedelics.

12:30 pm

Expand Stage

Longevity Market and Investment Landscape with Phil Newman

Featuring Phil Newman.

Gain an insider’s overview of the burgeoning longevity marketplace from digital investment platform founder and Editor-in-Chief of Longevity.Technology, Phil Newman. With decades of experience in marketing, business development, and management across sectors like biopharma, AI, and medical devices, Phil will provide insights into the financial landscape and investment strategies of extending healthy lifespan. He’ll outline the rapid growth of longevity investments and profile key companies shaping its future. Phil will share his vision for how investors can capitalize on advancements in regenerative medicine, diagnostics, AI to drive life-extension forward. Attendees will leave armed with an expert investor’s perspective on the high-potential longevity ecosystem.

12:30 pm

Explore Stage

The Truth Around Longevity

Featuring Adam Fried, Dr. Rafid Fadul, Rudy Inaba.

Longevity medicine has the potential to revolutionize healthcare and improve the lives of millions of people. Meanwhile, conventional healthcare providers are often hesitant to engage with new tests, therapies, and treatments due to potential risks and uncertainties. How should we differentiate between augmenting health for optimal, lifelong outcomes and an egocentric pursuit for longevity and self-discovery?

12:30 pm

Expand Stage

Intersection of Race and Mental Health

Featuring Danny Ross, Phoenix White, Aziza Kibibi, Martin Simms, Spring Washam, Sutton King.

Discussion on how racial and ethnic disparities impact mental health and strategies to reduce these disparities.

1:00 pm

Explore Stage

Psychedelic Investing, Boom, Bust, Boom

Featuring Richard Skaife, Maria Velkova, Brent Sobol, Yitz Klein, Dr. Doron Junger.

The psychedelic medicine market has experienced some drastic ups and downs. We’ve seen a boom and we’ve seen companies go bust. But with major clinical trials nearing completion and MAPS inching toward FDA approval, could there be another boom coming?

1:00 pm

Engage Stage

Branding in the Psychedelic Industry

Featuring Ashley Southard, Julie Zukof, Lara Pearson, Dr. Natanya Wachtel.

Psychedelic medicines offer immense potential for treating mental health conditions, but also carry cultural stigmas. As companies move these substances through medical and legal pathways, thoughtful branding is crucial. This panel explores best practices for branding in the psychedelic industry.

1:30 pm

Explore Stage

The Real Risks of the Psychedelic Renaissance

Featuring Jeremy Gardner.

From fake “shamans” and retreats to poorly designed academic studies and laws, the promise of psychedelics is matched only by the perils associated with them. Examining risks from both a historical and contemporary perspective, Gardner will explore how to avoid repeating the mistakes of the last century as well as not making new ones.

1:30 pm

Engage Stage

Mental Health and the Media: Responsible Reporting

Featuring Mattha Busby, Cynthia Salarizadeh, Danny-J Johnson, Madison Margolin, Sofie Mikhaylova.

Leading journalists discussed the best practices for covering mental health issues in the media. Panelists shared guidance on using non-stigmatizing language, considering impacts on vulnerable groups, providing appropriate context, and conveying messages of hope.

2:00 pm

Engage Stage

Betting on Long Life: Investing in the Quest for Longevity

Featuring Samina Rind.

Human longevity has increased dramatically over the past century, and scientific research continues to uncover new ways to extend the human lifespan even further. The fireside chat will explore Samina’s incredible achievement of a biological age of 21 at a 51-year calendar age, and her insights into the latest advances and investment opportunities in the burgeoning field of longevity science.

2:00 pm

Explore Stage

Investing in Mental Health: Challenges and Opportunities

Featuring Vic Pirotsky, Adam Wilkins, Garri Zmudze, Michael Snitkovsky, Khaliya White.

Exploring the intricacies of financing mental health programs. We’ll look at the obstacles and possible ways forward, underlining the promising prospects more investment could create.

2:00 pm

Engage Stage

Congressional / Federal Policy

Featuring Joshua Narrow, Tesla La Touche, Dena Ladd, Dr. Nick Brüss.

The psychedelic medicine landscape is rapidly evolving, with new research demonstrating therapeutic potential and jurisdictions beginning to reform laws. As momentum builds around psilocybin, MDMA, and other psychedelic compounds, what steps can policymakers take to support safe patient access and scientific progress? In this timely discussion, expert panelists closely monitoring federal policy developments will provide key insights for the psychedelics policy reform movement. They’ll examine the prospects for federal re- or de-scheduling efforts, discuss Congressional appetite for pro-psychedelic legislation, and explore FDA’s evolving regulatory approach as novel psychedelic therapies approach approval.

2:30 pm

Explore Stage

Psychedelics and Longevity: A Discussion on How Altered States Can Facilitate Change Leading to Happier and Healthier Lives

Featuring Michael Brotherton, Toby Pasman, Dr. Nicole Amada, Psychologist, PhD., Dr. Halland Chen, MD.

Join experts in the psychedelics and longevity space as they discuss the intersection of health and the mind, shedding light on how psychedelics can enhance our understanding of the human body and provide innovative opportunities for extending lifespan. Discover the latest groundbreaking research, personal experiences, and transformative insights that unveil the untapped potential of psychedelics to promote overall well-being. Embark on this mind-expanding journey to redefine the limits of human potential and explore new horizons in the quest for living greater lives.

2:30 pm

Engage Stage

Tai Chi & Qi Gong for Longevity

Featuring Dr. Jonathan Fields, DAOM, Joseph Shapiro.

Qi Gong – is the skill of cultivating life force energy to clear blockages, promote circulation, restore balance, and create unity of body, mind, and spirit. It is the science of longevity. Tai Chi – is an ancient martial art that includes gentle movements with a focus on grounding. It is ranked the #2 form of exercise by Harvard Health and is known for its ability to reduce stress, anxiety, and fatigue.

3:00 pm

Explore Stage

Do Hard Things On Purpose: Journeying from the Dead Sea to Mount Everest

Featuring Charlie Engle.

Charlie Engle is a world renowned ultra endurance athlete specializing in creating Impactful Resilience. He’s a vibrant speaker, best selling author, recovery addict and founding member of The Armada. He led a record setting run of nearly 5,000 miles across the Sahara Desert, making a film with Matt Damon and co-founding one of the worlds most impactful clean water nonprofits. Charlie uses powerful high touch coaching techniques to help people find their true north by Doing Hard Things On Purpose.

3:30 pm

Expand Stage

Underground Ripples: Lessons From the Underground and the Future of the Overground

Featuring Leonard Pickard, Patrick Moher, Simeon Schnapper.

Amidst the backdrop of a growing global movement advocating for the therapeutic potentials of psychedelics, a parallel and clandestine market thrives. Dive deep into the world of unauthorized psychedelic sales and dispensaries, exploring the motivations, risks, and implications for both practitioners and consumers. This comprehensive coverage sheds light on the challenges of regulating these potent substances, while also highlighting the necessity for safe and legal access to psychedelic therapies.

3:30 pm

Explore Stage

The Veteran’s Quest: My Battle for Better Mental Health Care

Featuring Giorgio Kirylo.

In an eye-opening keynote, Giorgio Kirylo relates his deeply personal story of serving his country and then fighting for proper mental health care upon returning home. He transports listeners through his deployments, the trauma he endured, and the frustrating bureaucracy he faced trying to get PTSD treatment. Kirylo makes a compelling case for expanding innovative therapies like ketamine to help veterans dealing with depression, anxiety, and trauma. Drawing on his own experience, he exposes the limitations in the current system while advocating for reforms to improve access and quality of care.

4:00 pm

Expand Stage

Understanding the Longevity Trend – The Biggest Opportunity of our Lifetimes

Featuring Cody Shirk.

Learn about why the next several decades will be unlike any other time in human history. As global populations around the world live longer, the longevity trend is not a speculation — it’s a certainty. Join Cody as he gives a macro view perspective on the world of longevity, and learn how nearly every industry will be affected by the coming shift in global demographics. This presentation is for investors, entrepreneurs, and anyone wanting to understand future consumer trends.

4:00 pm

The Sanctuary

The Sacred Journey: What Plant Medicine Retreats Teach Us

Featuring Greg Carrette, Anastasiya Kulygin, Satya Rita Rocha, Cori Sue Morris, Cam Leids, Lena Franklin.

Panelists will share how retreat ceremonies, activities, and integration practices can uncover deeper psychological and spiritual insights about oneself and our shared humanity. They will reflect on how retreats foster healing, self-understanding and provide tools that can positively impact our everyday lives and relationships back home. Whether you’re curious about attending a retreat yourself or simply want to learn, this session will provide an inside look at how the journey of plant medicines can be truly life changing.

4:30 pm

Expand Stage

Bringing Longevity Therapeutics to Market

Featuring Petr Sramek, Dr. Greg Bailey, Toby Sorabjee.

Scientists have made remarkable progress in understanding aging biology and developing interventions to extend a healthy lifespan. However, translating these discoveries into approved therapeutics remains challenging. In this panel, experts will discuss the cutting-edge science, clinical trials, regulations, business partnerships, and public engagement necessary to bring anti-aging treatments from lab to clinic.

4:30 pm

Engage Stage

Mushroom Cultivation: A Beginner’s Guide to Growing ‘Happy Mushrooms’ At Home for Improved Mental Health

Featuring Oliver Carlin.

Oliver Carlin, the founder of Curative Mushrooms, will reveal how a complete beginner can grow their own ‘happy mushrooms’ 100% legally at home in 30 days without needing any complicated instructions or expensive equipment. He will start with the easiest and cheapest ways for complete beginners and will then end with more advanced growing techniques for people who want to grow mushrooms in bulk, create their substrates from scratch, or even how to work with mushroom genetics and become advanced mycologists.